Development of a method to analyze a novel secretion gland specific gene.

开发一种分析新型分泌腺特异性基因的方法。

基本信息

  • 批准号:
    16590457
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

The novel Pi-a protein was expressed secretion gland, pituitary gland, stomach or pancreas, at mRNA level, but functions or protein expression were unknown. To understand its protein expression, I raised antibodies(Ab) against Pi-a,Firstly, I raised antisera against synthetic peptide and a recombinant protein. Synthesized peptide Pi-a(C+961〜972), common to human and mouse, was immunized, and antiserum showed good reaction to the native antigen. Recombinant protein, mouse Pi-a/His tag, was purified with His tag, immunized, and antiserum showed good reaction to the native antigen. When these antisera were tested by Western blot analyses, both of them failed to show specific signals for secretion glands. Thus I continued to raise further antisera. Three peptides, 154-168, 519-533, 999-101, were synthesized, immunized and antisera showed good reaction to the native antigen after purification by peptide affinity columns. By Western blot analyses, these antisera were tested for their specificity against secretion tissues, such as, pituitary gland, stomach and pancreas, but all of them failed to show specific signals for these tissues. To understand the physical functions of Pi-a, I planned to raise Pi-a deficient mice through gene ablation, I analyzed the nucleotide database elucidated human and mouse Pi-a genome structure with their promoters, and produced recombinant vector for knockout mouse. But further study was abandoned for the lack of antisera for Pi-a for further analyses
新的Pi-a蛋白在分泌腺、垂体、胃或胰腺中以mRNA水平表达,但其功能或蛋白表达尚不清楚。为了了解其蛋白质表达,我制备了针对 Pi-a 的抗体(Ab),首先,我制备了针对合成肽和重组蛋白的抗血清。采用人和小鼠常见的合成肽Pi-a(C+961〜972)进行免疫,抗血清对天然抗原表现出良好的反应。重组蛋白小鼠Pi-a/His标签,用His标签纯化,免疫,抗血清对天然抗原表现出良好的反应。当这些抗血清通过蛋白质印迹分析进行测试时,它们都未能显示出分泌腺的特异性信号。因此我继续进一步筹集抗血清。合成并免疫了三种肽:154-168、519-533、999-101,经肽亲和柱纯化后,抗血清对天然抗原表现出良好的反应。通过蛋白质印迹分析,测试了这些抗血清针对垂体、胃和胰腺等分泌组织的特异性,但均未能显示出针对这些组织的特异性信号。为了了解Pi-a的物理功能,我计划通过基因消融来饲养Pi-a缺陷小鼠,我分析了核苷酸数据库,阐明了人和小鼠Pi-a基因组结构及其启动子,并制作了敲除小鼠的重组载体。但由于缺乏 Pi-a 的抗血清进行进一步分析而放弃了进一步的研究

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
先天性TSH・GH・PRL複合欠損症(PIT1異常症・PROP1異常症)
先天性 TSH/GH/PRL 联合缺乏症(PIT1 异常/PROP1 异常)
Development of a radiotransporter assay for determination of iodide : preliminary studies.
开发用于测定碘化物的放射性转运蛋白测定法:初步研究。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Miyai;K.;Minekawa;T.;Tsutsumi;S.;Tatsumi;K.;Amino;N.
  • 通讯作者:
    N.
A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency.
合并垂体前叶激素缺乏症的日本兄弟姐妹中出现一种新的 PROP1 基因突变 (157delA)。
転写因子異常症のモデル疾患-PIT1異常症-
转录因子障碍模型疾病-PIT1障碍-
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    塚元和弘;河野 茂;巽 圭太
  • 通讯作者:
    巽 圭太
新領域別症候群シリーズ No.1内分泌症候群(I) -その他の内分泌疾患を含めて-
新区综合症系列第一号内分泌综合症(一)-包括其他内分泌疾病-
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    早田 宏;他;Higai Koji;巽 圭太
  • 通讯作者:
    巽 圭太
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TATSUMI Ke-ita其他文献

TATSUMI Ke-ita的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TATSUMI Ke-ita', 18)}}的其他基金

Development of a novel method to detect circulating tumor cells (CTCs) by expression of tissue specific mRNAs in peripheral blood.
开发了一种通过外周血中组织特异性 mRNA 的表达来检测循环肿瘤细胞 (CTC) 的新方法。
  • 批准号:
    24659277
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of novel quality control method using patients' results.
利用患者结果开发新的质量控制方法。
  • 批准号:
    19590557
  • 财政年份:
    2007
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a rapid genetic analysis method using little mRNA from blood samples
开发使用血液样本中少量 mRNA 的快速遗传分析方法
  • 批准号:
    10557250
  • 财政年份:
    1998
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

A Novel Gene Therapy Approach to Prevent Alpha-synuclein Misfolding in Multiple System Atrophy
一种防止多系统萎缩中α-突触核蛋白错误折叠的新基因治疗方法
  • 批准号:
    10673418
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Development of a Novel Gene Therapy for Neurodegenerative Diseases
神经退行性疾病新型基因疗法的开发
  • 批准号:
    10069789
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Collaborative R&D
Development of novel gene therapy for rhabdomyosarcoma
横纹肌肉瘤新型基因疗法的开发
  • 批准号:
    23K07230
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of innovative synthetic biology tools utilizing novel gene regulatory systems of in microorganisms
利用微生物中的新型基因调控系统开发创新的合成生物学工具
  • 批准号:
    23K18014
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Novel gene therapy platform for monogenetic lung diseases
单基因肺部疾病的新型基因治疗平台
  • 批准号:
    491900
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Elucidation of the physiological function of a novel gene associated with cellular lipid accumulation
阐明与细胞脂质积累相关的新基因的生理功能
  • 批准号:
    23K07979
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
I-Corps: A novel gene assay for accurate prognosis and prediction of clinical benefits of chemotherapy for early-stage non-small cell lung cancer
I-Corps:一种新型基因检测,用于准确预后和预测早期非小细胞肺癌化疗的临床益处
  • 批准号:
    2221895
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Standard Grant
Establishing a novel gene editing strategy for BBS7 using human retinal organoids
使用人类视网膜类器官建立 BBS7 的新型基因编辑策略
  • 批准号:
    10878639
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Examination of gut-microbiome-brain interactions in a novel gene x environment model of neurodevelopmental disorders
在神经发育障碍的新型基因 x 环境模型中检查肠道-微生物组-大脑相互作用
  • 批准号:
    10730191
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Development of a novel gene modification system for obligate anaerobes and its application to environmental measures
专性厌氧菌新型基因修饰系统的开发及其在环境措施中的应用
  • 批准号:
    22K12436
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了